This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
SunPower (SPWR) Tops Q4 Earnings Estimates
by Zacks Equity Research
SunPower (SPWR) delivered earnings and revenue surprises of 76.92% and -0.35%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Cadence Design Systems (CDNS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Cadence (CDNS) delivered earnings and revenue surprises of 1.89% and 0.52%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
HubSpot (HUBS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
HubSpot (HUBS) delivered earnings and revenue surprises of 7.14% and 2.88%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
International Flavors (IFF) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
International Flavors (IFF) delivered earnings and revenue surprises of 2.82% and 0.06%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Installed Building Products (IBP) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Installed Building Products (IBP) closed at $74.52 in the latest trading session, marking a -1.68% move from the prior day.
Intelsat (I) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Intelsat (I) closed at $3.29, marking a -1.79% move from the previous day.
American Tower (AMT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
American Tower (AMT) closed at $256.18 in the latest trading session, marking a +0.75% move from the prior day.
Maxar Technologies (MAXR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Maxar Technologies (MAXR) closed at $18.99, marking a +1.39% move from the previous day.
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CRISPR Therapeutics AG (CRSP) closed at $57.76 in the latest trading session, marking a +1.33% move from the prior day.
Sapiens (SPNS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Sapiens (SPNS) closed at $25.30 in the latest trading session, marking a -1.63% move from the prior day.
Leidos (LDOS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Leidos (LDOS) closed at $111 in the latest trading session, marking a -1.02% move from the prior day.
Coca-Cola FEMSA (KOF) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Coca-Cola FEMSA (KOF) closed at $64.52 in the latest trading session, marking a -0.66% move from the prior day.
Frontline (FRO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Frontline (FRO) closed at $8.35 in the latest trading session, marking a +0.24% move from the prior day.
Aimmune Therapeutics (AIMT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aimmune Therapeutics (AIMT) closed at $29.17 in the latest trading session, marking a -1.12% move from the prior day.
New Strong Buy Stocks for February 12th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
Low Mortgage Rates to Boost Housing Market: 5 Stocks to Buy
by Zacks Equity Research
Due to low interest rates and fears related to the spread of coronavirus, mortgage rates decline to lowest level since 2016. This in turn is expected to aid expansion of the U.S. housing industry.
Top Ranked Momentum Stocks to Buy for February 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 5th
Factors Likely to Shape Orion Energy's (OESX) Q3 Earnings
by Zacks Equity Research
Higher revenues resulting from major contribution from the national account segment and cost-saving initiatives are likely to get reflected on Orion Energy's (OESX) fiscal Q3 earnings.
Acuity Brands Benefits From Innovation Amid Soft Demand
by Zacks Equity Research
Acuity Brands's (AYI) innovative lighting solutions and acquisitions will drive overall growth. However, softness in the industry and higher costs raise concerns.
Here's Why Investors Should Steer Clear of Acuity Brands
by Zacks Equity Research
Weak industry prospects, and higher costs and expenses are hurting Acuity Brands' (AYI) performance.
Home Builders' Confidence Highest Since 1999: 5 Picks
by Zacks Equity Research
Housing starts and building permits saw an uptick in November and builder's confidence soared to the highest level since 1999.
Acuity Brands Unveils Versatile & Compact Modulus System
by Zacks Equity Research
Acuity Brands (AYI) launches innovative Modulus system to elevate luminaire design and reduce ownership cost.
The Zacks Analyst Blog Highlights: Jounce Therapeutics, Forterra, Hibbett Sports, Foundation Building Materials and Orion Energy Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Jounce Therapeutics, Forterra, Hibbett Sports, Foundation Building Materials and Orion Energy Systems
Small Business Optimism Rises Amid Trade Jitters: 5 Top Picks
by Nalak Das
A section of the U.S. business community - the small business segment - seems optimistic about the future despite trade-related hiccups.
Acuity Brands & CIRCADIAN to Commercialize Zirc Technology
by Zacks Equity Research
Acuity Brands (AYI) adds another innovative lighting control solution to its portfolio via its partnership with CIRCADIAN ZircLight.